Nurtec Odt Tablet, Orally Disintegrating
Product Images NDC 72618-3000
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Nurtec Odt (NDC 72618-3000). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Nurtec 02
Nurtec 03
This is a graph representing the percentage of individuals who achieved pain freedom with NURTEC ODT 75mg as compared to a placebo. The graph shows a 100% pain freedom rate with NURTEC ODT 75mg and a significantly lower rate with the placebo. The time frame for achieving pain freedom is also displayed in hours.*
Nurtec 04
The text is describing a graph showing the percentage of patients achieving MBS freedom after taking NURTEC ODT 75 mg compared to a placebo. The graph shows that at all time points from 0.5 to 20 hours after the dose, NURTEC ODT was significantly more effective in achieving MBS freedom compared to the placebo.*
Nurtec 05
Nurtec 06
Nurtec 07
Nurtec 10
Nurtec® ODT (rimegepant) is a medication that comes in the form of orally disintegrating tablets containing 75 mg of rimegepant. The medication is accessed by peeling back the foil from the blister pack and placing the tablet under or on top of the tongue where it dissolves within seconds. The recommended storage temperature is 68°F to 77°F (20°C to 25°C) with temporary excursions allowed between 59°F to 86°F (15°C to 30°C). For more information or questions about the medication, individuals can visit the Nurtec website or call the provided phone number.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.